Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

Primary resistance of human patients to botulinum neurotoxins A and B.

Pirazzini M, Carle S, Barth H, Rossetto O, Montecucco C.

Ann Clin Transl Neurol. 2018 Jul 17;5(8):971-975. doi: 10.1002/acn3.586. eCollection 2018 Aug.

2.

High Conservation of Tetanus and Botulinum Neurotoxins Cleavage Sites on Human SNARE Proteins Suggests That These Pathogens Exerted Little or No Evolutionary Pressure on Humans.

Carle S, Pirazzini M, Rossetto O, Barth H, Montecucco C.

Toxins (Basel). 2017 Dec 19;9(12). pii: E404. doi: 10.3390/toxins9120404.

3.

A comprehensive screening platform for aerosolizable protein formulations for intranasal and pulmonary drug delivery.

Röhm M, Carle S, Maigler F, Flamm J, Kramer V, Mavoungou C, Schmid O, Schindowski K.

Int J Pharm. 2017 Oct 30;532(1):537-546. doi: 10.1016/j.ijpharm.2017.09.027. Epub 2017 Sep 14.

4.

The Hsp90 machinery facilitates the transport of diphtheria toxin into human cells.

Schuster M, Schnell L, Feigl P, Birkhofer C, Mohr K, Roeder M, Carle S, Langer S, Tippel F, Buchner J, Fischer G, Hausch F, Frick M, Schwan C, Aktories K, Schiene-Fischer C, Barth H.

Sci Rep. 2017 Apr 4;7(1):613. doi: 10.1038/s41598-017-00780-x.

5.

Auranofin Inhibits the Enzyme Activity of Pasteurella multocida Toxin PMT in Human Cells and Protects Cells from Intoxication.

Carle S, Brink T, Orth JH, Aktories K, Barth H.

Toxins (Basel). 2017 Jan 13;9(1). pii: E32. doi: 10.3390/toxins9010032.

Supplemental Content

Loading ...
Support Center